The use of onabotulinum toxin A (Botox®) in the treatment of chronic migraine at the Parma Headache Centre: a prospective observational study
Crossref DOI link: https://doi.org/10.1007/s10072-016-2568-z
Published Online: 2016-04-05
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Russo, Marco
Manzoni, Gian Camillo
Taga, Arens
Genovese, Antonio
Veronesi, Licia
Pasquarella, Cesira
Sansebastiano, Giuliano Ezio
Torelli, Paola
Text and Data Mining valid from 2016-04-05